Author: Wu K.
Publisher: Springer Publishing Company
ISSN: 0939-5555
Source: Annals of Hematology, Vol.83, Iss.12, 2004-12, pp. : 779-783
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Iron-chelation therapy with oral chelators in patients with thalassemia major
By Uygun Vedat
Hematology, Vol. 18, Iss. 1, 2013-01 ,pp. :
By Ladis V. Berdousi H. Palamidou F. Agrafioti C. Papadopoulou A. Anagnostopoulos G. Theodorides C. Kattamis C.
Transfusion and Apheresis Science, Vol. 23, Iss. 3, 2000-12 ,pp. :
By Ladis V. Berdousi H. Palamidou F. Agrafioti C. Papadopoulou A. Anagnostopoulos G. Theodorides C. Kattamis C.
Transfusion Science, Vol. 23, Iss. 3, 2000-12 ,pp. :
Deferiprone versus Deferoxamine in Patients with Thalassemia Major: A Randomized Clinical Trial
By Maggio A. D'Amico G. Morabito A. Capra M. Ciaccio C. Cianciulli P. Di Gregorio F. Garozzo G. Malizia R. Magnano C. Mangiagli A. Quarta G. Rizzo M. D'Ascola D.G. Rizzo A. Midiri M.
Blood Cells, Molecules, and Diseases, Vol. 28, Iss. 2, 2002-02 ,pp. :